Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia.

Talati C, Dhulipala VC, Extermann MT, Ali NA, Kim J, Komrokji R, Sweet K, Kuykendall A, Sehovic M, Reljic T, Djulbegovic B, Lancet JE.

Haematologica. 2020 Jan 31;105(2):398-406. doi: 10.3324/haematol.2018.208637. Print 2020.

2.

Role of p21 and cyclin E in normal and secalonic acid D-inhibited proliferation of human embryonic palatal mesenchymal cells.

Dhulipala VC, Maddali KK, Ray BK, Welshons WV, Reddy CS.

Hum Exp Toxicol. 2011 Sep;30(9):1222-32. doi: 10.1177/0960327110387238. Epub 2010 Oct 18.

PMID:
20956459
3.

PKCdelta mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle.

Bowles DK, Maddali KK, Dhulipala VC, Korzick DH.

Am J Physiol Cell Physiol. 2007 Aug;293(2):C805-13. Epub 2007 May 16.

4.

Cell cycle proteins in normal and chemically induced abnormal secondary palate development: a review.

Dhulipala VC, Welshons WV, Reddy CS.

Hum Exp Toxicol. 2006 Nov;25(11):675-82. Review.

PMID:
17211986
5.

Secalonic acid D blocks embryonic palatal mesenchymal cell-cycle by altering the activity of CDK2 and the expression of p21 and cyclin E.

Dhulipala VC, Maddali KK, Welshons WV, Reddy CS.

Birth Defects Res B Dev Reprod Toxicol. 2005 Jun;74(3):233-42.

PMID:
15880679
6.
7.

Relevance of the palatal protein kinase A pathway to the pathogenesis of cleft palate by secalonic acid D in mice.

Dhulipala VC, Hanumegowda UM, Balasubramanian G, Reddy CS.

Toxicol Appl Pharmacol. 2004 Feb 1;194(3):270-9.

PMID:
14761683
8.

Supplemental Content

Loading ...
Support Center